99 related articles for article (PubMed ID: 4593269)
1. Rifampicin-dependent antibodies during intermittent treatment.
Virgilio R
Scand J Respir Dis Suppl; 1973; 84():83-6. PubMed ID: 4593269
[No Abstract] [Full Text] [Related]
2. Hong Kong Treatment Services-Royal Postgraduate Medical School-British Medical Research Council Co-operative study of rifampicin plus ethambutol in daily and intermittent regimens. The detection of rifampicin-dependent antibodies.
Worlledge S
Scand J Respir Dis Suppl; 1973; 84():60-3. PubMed ID: 4544603
[No Abstract] [Full Text] [Related]
3. Hong Kong Treatment Services-Royal Postgraduate Medical School-British Medical Research Council Co-operative study of rifampicin plus ethambutol in daily and intermittent regimens. Correlation between the presence of rifampicin-dependent antibodies and the clinical data.
Worlledge S
Scand J Respir Dis Suppl; 1973; 84():125-8. PubMed ID: 4522065
[No Abstract] [Full Text] [Related]
4. Haematological changes during intermittent treatment with rifampicin.
Wislawska-Orlowska B; Pniewski T
Scand J Respir Dis Suppl; 1973; 84():94-7. PubMed ID: 4522080
[No Abstract] [Full Text] [Related]
5. Rifampicin-dependent antibodies in twice-weekly treated patients.
Algeorge G; Rudescu D; Alexandrescu D
Scand J Respir Dis Suppl; 1973; 84():98-101. PubMed ID: 4522081
[No Abstract] [Full Text] [Related]
6. Proceedings of the Workshop on Intermittent Drug Therapy and Immunological Implications in Antituberculous Treatment with Rifampicin. Oct. 2-3, 1972 Stockholm. Organized by The Department of Thoracic Medicine, Karolinska Sjukhuset.
Scand J Respir Dis Suppl; 1973; 84():1-193. PubMed ID: 4593267
[No Abstract] [Full Text] [Related]
7. Immunological and haematological investigations on patients with adverse reactions during treatment with RMP plus INH once-weekly.
Herrmann H; Eule H
Scand J Respir Dis Suppl; 1973; 84():87-93. PubMed ID: 4593270
[No Abstract] [Full Text] [Related]
8. [Controlled comparison of daily and intermittent treatment regimens with rifampicin].
Yamamoto K
Bull Int Union Tuberc; 1974; 49(1):442-6. PubMed ID: 4619565
[No Abstract] [Full Text] [Related]
9. [Investigation on failures in the treatment of pulmonary tuberculosis with rifampicin. Tuberculosis Research Committee. RYOKEN].
Kekkaku; 1984 Feb; 59(2):91-104. PubMed ID: 6431172
[No Abstract] [Full Text] [Related]
10. [Daily and intermittent regimens using ethambutol and rifampicin in the treatment of unresponsive cases. (Evaluation after 1 year.) I. Clinical course].
Horsfall PA
Bull Int Union Tuberc; 1974; 49(1):447-51. PubMed ID: 4619566
[No Abstract] [Full Text] [Related]
11. Lack of effect of rifampin on the antibody response to a viral antigen in patients with tuberculosis.
Silvestri LG
Am Rev Respir Dis; 1975 Nov; 112(5):739-41. PubMed ID: 1190623
[TBL] [Abstract][Full Text] [Related]
12. [Intermittent treatment of "intractable chronic tuberculosis" by combined rifampicin-ethambutol: preliminary results of a controlled survey made in Algeria].
Larbaoui D; Chaulet P; Grosset J; Abderrahim K; Oussedik N; Coucke C; Benabdallah L
Rev Tuberc Pneumol (Paris); 1970 Jun; 34(4):559-66. PubMed ID: 4928583
[No Abstract] [Full Text] [Related]
13. Hong Kong Treatment Services-Royal Postgraduate Medical School-British Medical Research Council Co-operative study of rifampicin plus ethambutol in daily and intermittent regimens. Observations on antibody reaction scores on individual patients.
O'Mahony MG
Scand J Respir Dis Suppl; 1973; 84():64-72. PubMed ID: 4522079
[No Abstract] [Full Text] [Related]
14. [Rifampicin in the treatment of chronic pulmonary tuberculosis. Preliminary report].
Pacheco CR; Cordero O; López-Malagón S; Sierra D; De Jesús Pacheco M; Vázquez E
Gac Med Mex; 1973 Jun; 105(6):541-7. PubMed ID: 4731993
[No Abstract] [Full Text] [Related]
15. Controlled study on rifampicin in first treatment of fresh cases of pulmonary tuberculosis.
Kraan JK; Mulder RJ; van Dijk B
Acta Tuberc Pneumol Belg; 1969; 60(3):557-62. PubMed ID: 4906104
[No Abstract] [Full Text] [Related]
16. A cooperative study on rifampicin in original treatment of advanced pulmonary tuberculosis.
Gyselen A; Verbist L; Cosemans J; Lacquet LM; Prignot J; Simon-Pouthier F; Debrabandere R; Devriendt J
Acta Tuberc Pneumol Belg; 1969; 60(3):563-76. PubMed ID: 4906105
[No Abstract] [Full Text] [Related]
17. [Rifampicin and ethanbutol in daily and intermittent treatment of chronic advanced cavernous pulmonary tuberculosis resistant to many drugs. Preliminary communication. Early results].
Zierski M; Bek E; Kucharska A; Graczyk J; Bukalska Z
Gruzlica; 1973 Nov; 41(11):1129-37. PubMed ID: 4765793
[No Abstract] [Full Text] [Related]
18. [Rifampicin in the intermittent treatment of experimental tuberculosis in mice].
Lucchesi M; Matzeu M; Mancini P
G Ital Mal Torace; 1971; 25(6):313-8. PubMed ID: 5005063
[No Abstract] [Full Text] [Related]
19. Rifampicin in newly detected, untreated cases of pulmonary tuberculosis.
Meissner G
Acta Tuberc Pneumol Belg; 1969; 60(3):554-6. PubMed ID: 4906103
[No Abstract] [Full Text] [Related]
20. [Daily and intermittent regimens using ethambutol and rifampicin in the treatment of unresponsive cases. (Evaluation after 1 year.) II. Side effects].
Girling DJ
Bull Int Union Tuberc; 1974; 49(1):451-5. PubMed ID: 4619567
[No Abstract] [Full Text] [Related]
[Next] [New Search]
